Sunday
2:00 pm - 9:00 pm
Arrival and Check-in
6:00 pm - 7:00 pm
Dinner
7:30 pm - 7:40 pm
Introductory Comments by GRC Site Staff / Welcome from the GRC Chair
7:40 pm - 9:30 pm
Keynote Session: The Leading Edge in Uncovering Complex Drug Disposition and Toxicity
Discussion Leader: Swati Nagar (Temple University, USA)
7:40 pm - 7:55 pm
Opening Remarks
7:55 pm - 8:55 pm
Deanna Kroetz (University of California, San Francisco, USA)
"Reverse Translational Studies to Improve Drug Safety and Efficacy: The Power of Genomic Technology and Big Data"
8:55 pm - 9:30 pm
Discussion
Monday
7:30 am - 8:30 am
Breakfast
8:30 am - 9:00 am
Group Photo
9:00 am - 12:30 pm
New Knowledge on Structure and Function of Drug Metabolizing Enzymes
Discussion Leader: Nina Isoherranen (University of Washington, USA)
9:00 am - 9:05 am
Introduction by Discussion Leader
9:05 am - 9:35 am
D. Fernando Estrada (University at Buffalo, SUNY, USA)
"The Secret Handshake: Specificity in a Mitochondrial P450-Redox Partner Complex"
9:35 am - 9:50 am
Discussion
9:50 am - 10:20 am
Margaret James (University of Florida, USA)
"Structure and Function of Glutathione Transferases, with Focus on GSTZ1"
10:20 am - 10:35 am
Discussion
10:35 am - 11:00 am
Coffee Break
11:00 am - 11:30 am
Jeffrey Jones (Washington State University, USA)
"The Strange Kinetics of Aldehyde Oxidase and How This May Affect Drug Discovery"
11:30 am - 11:45 am
Discussion
11:45 am - 12:15 pm
Zeruesenay Desta (Indiana University School of Medicine, USA)
"Interplay of Genetic Variations and Drug-Drug Interactions"
12:15 pm - 12:30 pm
Discussion
12:30 pm - 1:30 pm
Lunch
1:30 pm - 4:00 pm
Free Time
4:00 pm - 6:00 pm
Poster Session
6:00 pm - 7:00 pm
Dinner
7:30 pm - 9:30 pm
The Cell Membrane in Relation to Enzymes and Transporters
Discussion Leader: Kenneth Korzekwa (Temple University, USA)
7:30 pm - 7:35 pm
Introduction by Discussion Leader
7:35 pm - 8:00 pm
Ute Hellmich (University of Mainz, Germany)
"The Power to Change: How to Translocate a Drug Across a Membrane?"
8:00 pm - 8:10 pm
Discussion
8:10 pm - 8:35 pm
Michal Otyepka (Palacký University Olomouc, Czech Republic)
"Biomembrane as a Spot Where Cytochrome P450 Enzymes Meet with Drugs and Third Parties"
8:35 pm - 8:50 pm
Discussion
8:50 pm - 9:15 pm
Ronald Oude Elferink (Academic Medical Center, The Netherlands)
"Membrane Asymmetry and Transporter Function"
9:15 pm - 9:30 pm
Discussion
Tuesday
7:30 am - 8:30 am
Breakfast
9:00 am - 12:30 pm
Drug-Drug Interactions and Toxicity
Discussion Leader: Upendra Argikar (Novartis, USA)
9:00 am - 9:05 am
Introduction by Discussion Leader
9:05 am - 9:35 am
R. Scott Obach (Pfizer Inc., USA)
"Reaction Phenotyping and Enzyme Identification: It's a Lot Harder than It Used to Be"
9:35 am - 9:50 am
Discussion
9:50 am - 10:20 am
Kim Brouwer (UNC Eshelman School of Pharmacy, USA)
"Novel In Vitro and In Silico Approaches to Predict Hepatic Bile Acid Transporter-Mediated DDIs and Drug-Induced Hepatotoxicity"
10:20 am - 10:35 am
Discussion
10:35 am - 11:00 am
Coffee Break
11:00 am - 11:30 am
Yuichi Sugiyama (RIKEN, Japan)
"Prediction of Complex Transporter (Uptake, Efflux) / Enzyme-Mediated Drug-Drug Interactions Using a Physiologically-Based Pharmacokinetic (PBPK) Model with In Vitro Ki Values"
11:30 am - 11:45 am
Discussion
11:45 am - 12:15 pm
Konstantine Skordos (Novartis, USA)
"Early Assessment of DDI Potential in (Oncology) Combination Clinical Trials"
12:15 pm - 12:30 pm
Discussion
12:30 pm - 1:30 pm
Lunch
1:30 pm - 4:00 pm
Free Time
4:00 pm - 6:00 pm
Poster Session
6:00 pm - 7:00 pm
Dinner
7:30 pm - 9:30 pm
Models for Complex Metabolism and Transport
Discussion Leader: Sukyung Woo (University of Oklahoma Health Sciences Center, USA)
7:30 pm - 7:35 pm
Introduction by Discussion Leader
7:35 pm - 8:00 pm
Daniel Scotcher (University of Manchester, United Kingdom)
"Mechanistic Model of Creatinine-Drug Interactions Accounting for the Role of Multiple Transporters and Passive Permeability"
8:00 pm - 8:10 pm
Discussion
8:10 pm - 8:35 pm
Valeriu Damian (GlaxoSmithKline, USA)
"Beyond PBPK: Modeling the Complex Biological Response to Local Drug Delivery"
8:35 pm - 8:50 pm
Discussion
8:50 pm - 9:15 pm
Greg Thurber (University of Michigan, USA)
"Measuring Single-Cell Pharmacokinetics and Pharmacodynamics in Tumors to Design More Efficient Biologics"
9:15 pm - 9:30 pm
Discussion
Wednesday
7:30 am - 8:30 am
Breakfast
9:00 am - 12:30 pm
Special Populations: Pediatric Drug Metabolism and Pharmacokinetics
Discussion Leader: Sara Van Driest (Vanderbilt University Medical Center, USA)
9:00 am - 9:20 am
Introduction by Discussion Leader
9:20 am - 9:50 am
Saskia de Wildt (Radboud University, The Netherlands)
"The Exciting Path Towards Elucidating Pediatric Drug Metabolism and Transport"
9:50 am - 10:05 am
Discussion
10:05 am - 10:40 am
Coffee Break
10:40 am - 11:10 am
Gilbert Burckart (U.S. Food and Drug Administration, USA)
"Past, Present and Future of Pediatric Drug Regulation"
11:10 am - 11:25 am
Discussion
11:25 am - 11:55 am
Tracy McGregor (Alnylam Pharmaceuticals, USA)
"Opportunities and Challenges for Drug Development for Pediatric Patients"
11:55 am - 12:10 pm
Discussion
12:10 pm - 12:30 pm
General Discussion
12:30 pm - 1:30 pm
Lunch
1:30 pm - 4:00 pm
Free Time
4:00 pm - 6:00 pm
Poster Session
6:00 pm - 7:00 pm
Dinner
7:00 pm - 7:30 pm
Business Meeting
Nominations for the Next Vice Chair; Fill in Conference Evaluation Forms; Discuss Future Site and Scheduling Preferences; Election of the Next Vice Chair
7:30 pm - 9:30 pm
Young Investigator Presentations
Oral presentations by graduate students and postdoctoral trainees, selected from submitted abstracts.
Discussion Leader: Patrick Murphy (Academic Consultant, USA)
7:30 pm - 7:45 pm
Selected from Poster Abstracts: Matthew Albertolle (Vanderbilt University, USA)
"Sulfenylation of Human Kidney and Liver Drug Metabolizing Enzymes: A Possible Redox Switch that Modulates Catalytic Activity"
7:45 pm - 7:50 pm
Discussion
7:50 pm - 8:05 pm
Selected from Poster Abstracts: Olena Anoshchenko (University of Washington, USA)
"Gestational Age-Dependent Abundance of Drug Transporters in Human Placentae Quantified by LC-MS/MS Proteomics"
8:05 pm - 8:10 pm
Discussion
8:10 pm - 8:25 pm
Selected from Poster Abstracts: Jacqueline Bezencon (University of North Carolina at Chapel Hill, USA)
"Polycystic Kidney and Liver Disease in Rats Alters Expression and Function of Hepatic and Renal Drug Transporters"
8:25 pm - 8:30 pm
Discussion
8:30 pm - 8:45 pm
Selected from Poster Abstracts: Robert Jones (University at Buffalo, USA)
"Metabolomic/Proteomic Analyses of Orphan Transporter Monocarboxylate Transporter 6 (MCT6): Evidence of a Role in Lipid Metabolism"
8:45 pm - 8:50 pm
Discussion
8:50 pm - 9:05 pm
Selected from Poster Abstracts: Annika Wagner (Johannes Gutenberg-Universität Mainz, Germany)
"Inhibition Induced Dimerization of an Essential Oxidoreductase from African Trypanosomes"
9:05 pm - 9:10 pm
Discussion
9:10 pm - 9:25 pm
Selected from Poster Abstracts: Muluneh Fashe (National Institute of Environmental Health Sciences, NIH, USA)
"Phenobarbital Signals Nuclear Receptor CAR to Recruit RORa to Activate the CYP2B6 Gene via Phosphorlyation"
9:25 pm - 9:30 pm
Discussion
Thursday
7:30 am - 8:30 am
Breakfast
9:00 am - 12:30 pm
Special Populations: Intricacies in Drug Disposition
Discussion Leader: Rebecca Blanchard (CRISPR Therapeutics, USA)
9:00 am - 9:05 am
Introduction by Discussion Leader
9:05 am - 9:35 am
Kenneth Thummel (University of Washington, USA)
"Unique Gene Alleles and Population Frequencies: Implications for Metabolic Drug Clearance"
9:35 am - 9:50 am
Discussion
9:50 am - 10:20 am
John Clarke (Washington State University, USA)
"Overlapping Hits on Drug Disposition: Special Populations Within Special Populations"
10:20 am - 10:35 am
Discussion
10:35 am - 11:00 am
Coffee Break
11:00 am - 11:30 am
Lauren Aleksunes (Rutgers University, USA)
"Lipid Regulation of Placental Xenobiotic Transport"
11:30 am - 11:45 am
Discussion
11:45 am - 12:15 pm
J. Steven Leeder (Children's Mercy Hospital, USA)
"Variability in Drug Disposition in Children: Beyond Ontogeny and Genetic Variation"
12:15 pm - 12:30 pm
Discussion
12:30 pm - 1:30 pm
Lunch
1:30 pm - 4:00 pm
Free Time
4:00 pm - 6:00 pm
Poster Session
6:00 pm - 7:00 pm
Dinner
7:30 pm - 9:30 pm
The Complexity of Regulation: FDA Guidelines and Case Studies
Discussion Leader: Donald Tweedie (Merck, USA)
7:30 pm - 7:35 pm
Introduction by Discussion Leader
7:35 pm - 8:00 pm
Thomas Baillie (University of Washington, USA)
"Metabolites in Safety Testing (MIST) 16 Years On: Has Regulatory Guidance Led to Safer Drugs?"
8:00 pm - 8:10 pm
Discussion
8:10 pm - 8:35 pm
Shiew-Mei Huang (U.S. Food and Drug Administration, USA)
"Evolution of the Role of Clinical Pharmacology in Drug Development and Regulatory Review"
8:35 pm - 8:50 pm
Discussion
8:50 pm - 9:15 pm
Karsten Menzel (Merck, USA)
"Regulatory Feedback on Letermovir PBPK Modeling of Simulating CYP2C8 Drug Interactions"
9:15 pm - 9:30 pm
Discussion
Friday
7:30 am - 8:30 am
Breakfast
9:00 am
Departure